Yahoo Finance • 27 days ago
Revenue: $319 million, an increase of 10% versus 2023. Cardiopulmonary Segment Revenue: $174 million, an increase of 14% versus Q2 2023. Heart-Lung Machine Revenue: Increased over 25% driven by Essenz. Oxygenator Revenue: Grew more than 15... Full story
Yahoo Finance • 8 months ago
LivaNova PLC (NASDAQ:LIVN) Q4 2023 Earnings Call Transcript February 21, 2024 LivaNova PLC beats earnings expectations. Reported EPS is $0.87, expectations were $0.79. LIVN isn't one of the 30 most popular stocks among hedge funds at the... Full story
Yahoo Finance • 9 months ago
William Kozy will remain Board Chair LONDON, February 05, 2024--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its Board of Directors named Vladimir A. Makatsaria as the Company’... Full story
Yahoo Finance • last year
LONDON, November 01, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2023 and raised full-year 2023 revenue and adjusted diluted ea... Full story
Yahoo Finance • last year
The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund returned 7.7% gross (7.5%... Full story
Yahoo Finance • last year
Mechelen, Belgium;15June 2023,22:01 CET;regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Thad Huston as Chief Financial Officer (CFO) and Chief Operating Officer (COO) as per 1 July 2023. Mr... Full story
Yahoo Finance • last year
Mechelen, België;15 juni 2023,22:01 CET;gereglementeerde informatie - Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de benoeming aan van Thad Huston als Chief Financial Officer (CFO) en Chief Operating Officer (COO) per 1 juli 20... Full story
Yahoo Finance • last year
LONDON, June 13, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study, "A Pro... Full story
Yahoo Finance • last year
In this piece, we will take a look at the top 15 stock picks of David Einhorn's 2023 portfolio. For more stock picks, head on over to David Einhorn's 2023 Portfolio: Top 5 Stock Picks. After the unexpected beating that investors and the s... Full story
Yahoo Finance • 2 years ago
LONDON, March 09, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lu... Full story
Yahoo Finance • 2 years ago
LONDON, February 08, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release h... Full story